Second Sight is backed in part by the billionaire medical device investor Al Mann, who is its chairman, and by the legendary device inventor and venture capitalist Thomas Forgarty.
"While we have a good success rate to get patients to survive and back to normal, almost none of them go on to bear children, " said Dr. Thomas Fishbein, Executive Director at the Georgetown Transplant Institute, who was not part of Al Ansari's medical team.